DAFNA Capital Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
AC
SCM
DAFNA Capital Management's BLUE Position: Q1 2021 in Review
DAFNA Capital Management sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 2,337 shares — an estimated $1.31M sold.
DAFNA Capital Management first reported a position in BLUE in Q3 2014 and held it in 25 quarters. The position peaked at $4.25M in Q1 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.
- DAFNA Capital Management reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
- DAFNA Capital Management sold 2,337 bluebird bio shares in Q1 2021, an estimated $1.31M.
- DAFNA Capital Management first reported a position in bluebird bio in Q3 2014 and held it in 25 quarters.
- DAFNA Capital Management's bluebird bio position peaked at $4.25M in Q1 2019.
- 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.
Based on DAFNA Capital Management's 13F filing for Q1 2021, filed 17 May 2021.